Vioxx Deal Yields Lawyer Payday

Law360, New York (November 9, 2007, 12:00 AM EST) -- The settlement reached in the Vioxx product liability litigation has been touted as a victory for both plaintiffs and drug maker Merck & Co. Inc. But the deal also means a major payday for a third party: the plaintiffs attorneys.

The terms of Merck & Co. Inc.'s $4.85 billion settlement, disclosed on Friday, stipulate that 85% of plaintiffs with pending or tolled claims must opt into the settlement process in order for the deal to go through. If the requisite number of plaintiffs do not initiate...
To view the full article, register now.